news
Neratinib defeats the Ras genes notorious for causing cancer
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
List view / Grid view
Genomics
news
Microcapsules to enhance the efficiency of genome-editing
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
news
Bluebird bio joins the ABPI as a full member
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
news
BC Platforms launches global genomics and clinical data analytics resource
A world leader in genomic data has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data...
news
UK Biobank releases genetic data on 0.5m people
Genetic data on half a million people was made available for research last week by the UK Biobank study. Information about participants’ health and well-being, key body measurements, their diet, occupational history, mental health and activity levels are also included...
article
83% of life science leaders believe blockchain will be adopted within 5 years
Just under a quarter (22%) of life science companies already using or experimenting with blockchain, but industry collaboration over security and storage standards is needed…
news
Collaboration is ‘game changer’ in delivering cell and gene therapies
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.
news
Study finds genetic basis for drug response in childhood absence epilepsy
13 April 2017 | By Niamh Marriott, Junior Editor
A new childhood absence epilepsy study has identified genes that show individual reactions and could be used as a precision medicine approach...
article
Democratising clinical genomics while protecting data privacy
1 February 2017 | By Jurgi Camblong (CEO, Sophia Genetics)
Sophia Genetics co-founder and CEO, Jurgi Camblong, tackles issues of privacy and security for healthcare patient data...
news
Sophia Genetics’ data-driven technology gives actionable cancer information
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The new data-driven tech, OncoPortal, improves the diagnosis and treatment of solid tumours and haematological malignancies for patients around the world...
webinar
Knockout screening with Sanger arrayed genome-wide CRISPR libraries
7 April 2016 | By Merck KGaA
In this webinar, we present the first genome wide, arrayed guide RNA screening libraries for CRISPR-Cas9.
news
DiscoverX and the SGC partner to make an annotated collection of >600 kinase inhibitors freely available
4 March 2016 | By DiscoverX
DiscoverX Corporation announced its partnership with the Structural Genomics Consortium (SGC)...
news
Broad Institute Genomic Services offers genomic insight into Ninlaro
25 January 2016 | By Victoria White
Ninlaro (ixazomib) was recently approved by the FDA, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma...
news
New Lymphocyte Genome Sensitivity assay can potentially identify patients with any cancer
17 September 2015 | By Andor
Andor Komet software characterises ‘Comets’ to detect Cancer...
article
Next-generation transcriptomic analysis in cancer vascular research
3 September 2015 | By Joseph W. Wragg and Roy Bicknell, University of Birmingham
Over the past decade significant advances have been made in the fields of genomic and transcriptomic profiling, inspired by the advent of next-generation sequencing (NGS). Yet despite the considerable promise of these new technologies, uptake has been slow. The focus of this review is the use of next-generation transcriptomic analysis…
